Healthcare -
Biotechnology - NASDAQ - US
$ 13.49
-0.369 %
$ 195 M
Market Cap
0.11
P/E
INBX - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities INBX - Inhibrx Biosciences, Inc.
-4.59 M
LAST VALUE
-138.27%
2 YEAR CAGR
-26.30%
5 YEAR CAGR
0.00%
10 YEAR CAGR